Finding of no Significant Impact for Genetically Engineered Atlantic Salmon (AquAdvantage Salmon)

This Notice document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder  Docket folder icon


View document:



Finding of no Significant Impact for Genetically Engineered Atlantic Salmon AquAdvantage Salmon

View Attachment:

Comment Period Closed
Apr 26 2013, at 11:59 PM ET
ID: FDA-2011-N-0899-0003

Document Information

Date Posted: Dec 27, 2012
RIN: Not Assigned
Show More Details  


Comments Received*
See attached file(s)
LabelGMOs comments Part 3 of 8 Since it is now fully documented in a Canadian study that the blood of the majority of pregnant women, their fetuses and non...
U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Docket No. FDA-2011-N-0899-0003 To Whom it May Concern: I am writing to...

Docket Information

This document is contained in
Related Comments:

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.